Mefloquine HCL Tablets — Class II drug recall D-1396-2012
Terminated recall by Teva Pharmaceuticals USA, Inc., reported 2012-07-04, distributed nationwide. Tablet Thickness: Product is being recalled due to the potential of being underweight or overweight.
| Recall number | D-1396-2012 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Teva Pharmaceuticals USA, Inc., Sellersville, PA, United States |
| Recall initiated | 2012-04-02 |
| Classified | 2012-06-26 |
| Reported by FDA | 2012-07-04 |
| Terminated | 2013-03-22 |
| Distributed | Nationwide (US) |
| NDC | 00555-0171, 00555-0171-78, 00555-0171-88 |
| Lot numbers | 34000741A |
| Expiration dates | 2013-07 |
Product
Mefloquine HCL Tablets, 250 mg, 5 tablets per blister pack; 5 Blister packs per carton, Rx only, Teva Pharmaceuticals USA Sellersville, PA 18960, Individual blister pack: NDC 0555-0171-88, 25 Unit-Dose Tablets (5x5) Carton: NDC 0555-0171-78
Reason for recall
Tablet Thickness: Product is being recalled due to the potential of being underweight or overweight.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1396-2012. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.